PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-289

Hello Adreamer,

You posted a while back could MPL be effective as a treatment in long " brain " Covid. It has taken a while for me to sort this out due to cross referencing.
The rationale for MPL treating MND is different. Remembering , MPL is a very specific niche drug, but some uses are forgotten due cross treatments, if that makes sense .

https://www.deseret.com/coronavirus/2022/1/21/22894780/mild-covid-19-symptoms-brain-damage-side-effects



So that's today news article with a link to this study.

Mild respiratory SARS-Cov-2 infection can cause multi lineage cellular dysregulation and myelin loss in the brain . Fernandez et al 2022.

So Adreamer, if you then go to this next study you will go more in
as to cytokines actions in the brain causing neuroinfllamation.

The effects of Covid 19 on NF-kB and neurological manifestations . Davies et Al 2021

Adreamer you said there could be a link with MPL. Have a read of this to establish that. MPL is such a good drug. Don't let "anyone" sell it for less than what's it's worth. We have only scratched it's potential.

Very well done Adreamer in bringing it to our attention. A very big hand clap !

Monepantel exerts anti inflammatory properties in murine models macrophages with possible mediation through NF-kB signalling. Ataie et Al 2014.